Startup ConsortiaTX finalized an agreement late last week to license a microbiome therapy from Brigham and Women’s Hospital and Boston Children’s Hospital.
You are here: / / Brigham-born biotech startup testing food allergy drug
2223 Avenida de la Playa
La Jolla CA 92037
Consortia Therapeutics develops microbial therapies to prevent and treat human disease.
Our work is based upon evidence-based studies from the Massachusetts Host Microbiome Center and the research of it’s scientific founders.